Wang Ling, Higashiura Katsuhiro, Ura Nobuyuki, Miura Tetsuji, Shimamoto Kazuaki
Department of Traditional Chinese Medicine, Beijing Hospital, the Ministry of Public Health, Beijin, PR China.
Hypertens Res. 2003 Jul;26(7):527-32. doi: 10.1291/hypres.26.527.
Insulin resistance and hyperinsulinemia are common findings in patients with essential hypertension. These impairments in glucose metabolism are commonly associated with diabetes mellitus, hypertension, and dyslipidemia, which are high risk factors of cardiovascular diseases, and recent evidence indicates that they may play a role in the development of coronary artery disease. The aim of this study was to determine the effect of Jiang-Tang-Ke-Li (JTKL), a traditional Chinese medicine used to treat diabetes mellitus in China, on insulin resistance and hypertension in fructose-fed rats (FFR). Systolic blood pressures in the FFR groups were significantly higher than that in the control group, although JTKL had no effect on systolic blood pressure for the last 2 weeks of treatment with the medicine. The average rate of glucose infusion during a glucose clamp, as an index of insulin sensitivity (M value), was significantly lower in the FFR than in the control rats, and treatment with JTKL for 2 weeks significantly increased the M value to that of the control. Treatment with Panax ginseng (PG), a component of JTKL, for 2 weeks also significantly increased the M value of FFR to the control level. The composite ratio of type I fibers in soleus muscle decreased significantly in the FFR compared to that in the control, and treatment with JTKL led to recovery of the composite ratio of type I fibers to the same level as that of the control group. The M value showed a significant positive correlation with the composite ratio of type I fibers and a significant negative correlation with the composite ratio of type II fibers. Tumor necrosis factor (TNF)-alpha levels were significantly higher in the soleus and extensor digitorum longus (EDL) muscles of the FFR than in those of the control rats. Treatment with JTKL for 2 weeks significantly lowered TNF-alpha levels to the control levels. M values showed a significant negative correlation with TNF-alpha in both the soleus and EDL muscles. The results suggest that the Chinese medicine JTKL, which contains PG as one of its valid components, improves insulin resistance by modulating muscle fiber composition and TNF-alpha in skeletal muscles in hypertensive and insulin-resistant FFR.
胰岛素抵抗和高胰岛素血症在原发性高血压患者中很常见。这些糖代谢障碍通常与糖尿病、高血压和血脂异常相关,而这些都是心血管疾病的高危因素,最近有证据表明它们可能在冠状动脉疾病的发展中起作用。本研究的目的是确定在中国用于治疗糖尿病的中药降糖颗粒(JTKL)对果糖喂养大鼠(FFR)胰岛素抵抗和高血压的影响。FFR组的收缩压显著高于对照组,尽管在药物治疗的最后2周JTKL对收缩压没有影响。葡萄糖钳夹期间的平均葡萄糖输注率作为胰岛素敏感性指标(M值),FFR组显著低于对照大鼠,JTKL治疗2周可使M值显著升高至对照水平。JTKL的成分人参(PG)治疗2周也可使FFR的M值显著升高至对照水平。与对照组相比,FFR比目鱼肌中I型纤维的复合比例显著降低,JTKL治疗可使I型纤维的复合比例恢复至与对照组相同水平。M值与I型纤维的复合比例呈显著正相关,与II型纤维的复合比例呈显著负相关。FFR比目鱼肌和趾长伸肌(EDL)中的肿瘤坏死因子(TNF)-α水平显著高于对照大鼠。JTKL治疗2周可使TNF-α水平显著降低至对照水平。比目鱼肌和EDL肌肉中的M值与TNF-α均呈显著负相关。结果表明,含有PG作为有效成分之一的中药JTKL通过调节高血压和胰岛素抵抗的FFR骨骼肌中的肌纤维组成和TNF-α来改善胰岛素抵抗。